Therefore, we proposed a novel and promising inflammation index-BAN score based on a combination of patient's BMI, ALB and NLR to reflect the degree of systemic inflammation response in resectable ESCC. This evidence concerns the gene ALB and esophageal squamous cell carcinoma.